CVS Health (CVS) Tops Q1 EPS by 33c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS Health Reports Strong First Quarter Results
May 4, 2021 6:30 AM EDTWOONSOCKET, R.I., May 4, 2021 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2021.
First Quarter Highlights:
Total revenues increased to $69.1 billion, up 3.5% compared to prior year GAAP diluted EPS of $1.68, up 9.8% compared to prior year Adjusted EPS of $2.04, up 6.8% compared to prior year Generated cash flow from operations of $2.9 billion2021 Full Year Guidance:
Raised GAAP diluted EPS guidance range to $6.24 to $6.36 from $6.06 to $6.22... More


